ArticleBehavioral neuroscience2011
The risky business of dopamine agonists in Parkinson disease and impulse control disorders.
Daniel O Claassen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
50 papers cite it
this papertrialcites it